COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Art Pappas will speak at the Drug Repositioning Summit on October 6 in Boston, MA
News | 10. 06. 2008
